Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2025-12-24 @ 7:54 PM
NCT ID:
NCT05982704
Eligibility Criteria:
Inclusion Criteria:
* Patient's signature of an informed consent form.
* Men and women aged 18 years or older.
* Confirmed diagnosis of new coronavirus infection COVID-19.
* Appearance of COVID-19 symptoms within 7 days prior to study inclusion
* Risk factors for COVID-19 progression and severity.
Exclusion Criteria:
* Patients with hypersensitivity to the active substance or other excipients (for the "Evusheld" product group: histidine, histidine hydrochloride monohydrate, sucrose, polysorbate 80, methionine; for the "Regkiron" product group: L-histidine, L-histidine monohydrate, polysorbate 80, L-arginine monohydrate)
* Patients with a history of anaphylactic reactions to drugs of monoclonal antibody class.
* Need for oxygen therapy at the time of study inclusion.
* Pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05982704
Study Brief:
Protocol Section:
NCT05982704